Marathon Petroleum Corporation (MPC)
NYSE: MPC · Real-Time Price · USD
165.53
-4.66 (-2.74%)
At close: Aug 1, 2025, 4:00 PM
170.87
+5.34 (3.23%)
After-hours: Aug 1, 2025, 7:46 PM EDT
Augmedix Stock Forecast
Stock Price Forecast
The 13 analysts that cover Augmedix stock have a consensus rating of "Buy" and an average price target of $185.23, which forecasts a 11.90% increase in the stock price over the next year. The lowest target is $170 and the highest is $205.
Price Target: $185.23 (+11.90%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Augmedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 4 | 4 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $175 → $182 | Hold | Maintains | $175 → $182 | +9.95% | Jul 22, 2025 |
| Citigroup | Citigroup | Hold Maintains $144 → $182 | Hold | Maintains | $144 → $182 | +9.95% | Jul 16, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $160 → $182 | Buy | Maintains | $160 → $182 | +9.95% | Jul 16, 2025 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $180 → $200 | Strong Buy → Buy | Downgrades | $180 → $200 | +20.82% | Jul 15, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 14, 2025 |
Financial Forecast
Revenue This Year
129.56B
from 139.34B
Decreased by -7.02%
Revenue Next Year
125.10B
from 129.56B
Decreased by -3.44%
EPS This Year
8.36
from 10.08
Decreased by -17.08%
EPS Next Year
12.07
from 8.36
Increased by 44.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 159.4B | 168.0B | 144.9B | ||
| Avg | 129.6B | 125.1B | 135.3B | ||
| Low | 108.0B | 83.5B | 126.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.4% | 29.7% | 15.8% | ||
| Avg | -7.0% | -3.4% | 8.2% | ||
| Low | -22.5% | -35.5% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.70 | 17.90 | 21.21 | ||
| Avg | 8.36 | 12.07 | 14.28 | ||
| Low | 3.82 | 7.65 | 6.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 55.7% | 114.2% | 75.7% | ||
| Avg | -17.1% | 44.4% | 18.3% | ||
| Low | -62.1% | -8.4% | -42.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.